dactinomycin has been researched along with aclarubicin in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 4 (40.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Reinert, KE | 1 |
Lin, J; Sartorelli, AC | 1 |
Hassan, HT; Rees, JK | 1 |
Boldt, J; Marquardt, H; Schaefer, A; Steinheider, G; Westendorf, J | 1 |
Ito, K; Kanoh, T; Kasakura, S; Mizuno, Y; Osamura, Y; Sotobayashi, H; Toyokawa, Y; Uchino, H; Uchiyama, T; Yoshida, Y | 1 |
Hayakawa, O; Kudo, R; Takehara, M | 1 |
Marquardt, H; Schaefer, A; Stöcker, U | 1 |
Amley, J; Chan, PK; Koller, CA; Qi, Y | 1 |
Harada, M; Ikeda, K; Ishimaru, F; Kiguchi, T; Kiura, K; Miyazono, T; Nakata, Y; Niiya, K; Shibakura, M; Shinagawa, K | 1 |
Duverger, A; Jones, J; Kappes, J; Kutsch, O; Shishido, T; Wagner, F; Wolschendorf, F | 1 |
10 other study(ies) available for dactinomycin and aclarubicin
Article | Year |
---|---|
DNA-helix bending, stiffening and elongation on ligand binding; analysis for several DNA-drug systems, general viscometric DNA response and stereochemical implications.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Dactinomycin; Daunorubicin; DNA; Intercalating Agents; Ligands; Mitomycin; Models, Molecular; Nucleic Acid Conformation; Viscosity | 1991 |
Stimulation by interferon of the differentiation of human promyelocytic leukemia (HL-60) cells produced by retinoic acid and actinomycin D.
Topics: Aclarubicin; Cell Differentiation; Cell Division; Cell Line; Dactinomycin; Drug Synergism; Humans; Interferons; Leukemia, Myeloid, Acute; Naphthacenes; Tretinoin | 1987 |
Low concentrations of cytosine arabinoside, 6-thioguanine, actinomycin-D and aclacinomycin A stimulates the differentiation of normal human marrow myeloid progenitor cells.
Topics: Aclarubicin; Adult; Aged; Bone Marrow; Bone Marrow Cells; Cell Differentiation; Cell Division; Cells, Cultured; Cytarabine; Dactinomycin; Female; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Thioguanine | 1989 |
Inhibition of amino acid uptake and incorporation into proteins in Friend erythroleukemia cells by the anthracycline antitumor antibiotic aclacinomycin A.
Topics: Aclarubicin; Alanine; Amino Acids; Aminoisobutyric Acids; Animals; Antibiotics, Antineoplastic; Cell Division; Dactinomycin; Dose-Response Relationship, Drug; Friend murine leukemia virus; Leukemia, Erythroblastic, Acute; Naphthacenes; Protein Biosynthesis; Rabbits; Tumor Cells, Cultured | 1988 |
[A case of primary macroglobulinemia responded to actinomycin D and aclacinomycin A].
Topics: Aclarubicin; Antibiotics, Antineoplastic; Blood Viscosity; Dactinomycin; Humans; Male; Middle Aged; Naphthacenes; Waldenstrom Macroglobulinemia | 1984 |
[Experimental and clinical study on chemotherapy for cervical adenocarcinoma].
Topics: Aclarubicin; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitomycin; Neoplasm Transplantation; Uterine Cervical Neoplasms | 1995 |
DMSO-like rapid decrease in c-myc and c-myb mRNA levels and induction of differentiation in HL-60 cells by the anthracycline antitumor antibiotic aclarubicin.
Topics: Aclarubicin; Cell Differentiation; Cell Division; Dactinomycin; Dimethyl Sulfoxide; Doxorubicin; Genes, myc; Humans; Leukemia, Promyelocytic, Acute; Novobiocin; Oncogenes; RNA, Messenger; Superoxides | 1995 |
Quantitation of the nucleophosmin/B23-translocation using imaging analysis.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Nucleolus; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Humans; Image Processing, Computer-Assisted; Leukemia, Monocytic, Acute; Nuclear Proteins; Nucleophosmin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1996 |
Induction of urokinase-type plasminogen activator by the anthracycline antibiotic in human RC-K8 lymphoma and H69 lung-carcinoma cells.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Antioxidants; Blotting, Northern; Cell Nucleus; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Humans; Lung Neoplasms; Lymphoma; Oligonucleotide Array Sequence Analysis; Protein Synthesis Inhibitors; RNA, Messenger; Time Factors; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2001 |
Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.
Topics: Aclarubicin; Anti-HIV Agents; Cell Differentiation; Cell Line; Dactinomycin; Drug Evaluation, Preclinical; HIV Infections; HIV-1; Humans; T-Lymphocytes; Virus Activation; Virus Latency | 2012 |